PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $56.11 per share as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $56.11.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $56.40.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $56.36.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $56.51.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed |
|---|---|---|
| 2026-06-30 | $56.11 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $56.40 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $56.36 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $56.51 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $57.00 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $52.22 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $51.10 10-Q · filed 2026-02-05 | |
| 2024-09-30 | $51.14 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $51.01 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $48.30 10-K · filed 2026-05-14 | |
| 2023-12-31 | $47.18 10-Q · filed 2025-02-06 | |
| 2023-09-30 | $47.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $46.54 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $43.96 10-K · filed 2026-05-14 | $43.95 10-K · filed 2023-05-05 |
| 2022-12-31 | $43.94 10-Q · filed 2024-02-08 | |
| 2022-09-30 | $42.88 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $42.88 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $40.62 10-K · filed 2025-05-09 | |
| 2021-12-31 | $40.54 10-Q · filed 2023-02-02 | |
| 2021-09-30 | $39.58 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $39.24 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $37.92 10-K · filed 2024-05-15 | |
| 2020-12-31 | $37.61 10-Q · filed 2022-02-03 | |
| 2020-09-30 | $37.55 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $37.53 10-Q · filed 2021-08-05 | |
| 2020-03-31 | $35.90 10-K · filed 2023-05-05 | |
| 2019-12-31 | $36.14 10-Q · filed 2021-02-04 | |
| 2019-09-30 | $35.90 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $36.07 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $38.45 10-K · filed 2022-05-06 | |
| 2018-12-31 | $38.45 10-Q · filed 2020-02-06 | |
| 2018-09-30 | $38.03 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $38.61 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $41.79 10-K · filed 2021-05-07 | |
| 2017-12-31 | $41.77 10-Q · filed 2019-02-07 | |
| 2017-09-30 | $41.80 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $41.42 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $37.70 10-K · filed 2020-05-08 | |
| 2016-12-31 | $37.54 10-Q · filed 2018-02-01 | |
| 2016-09-30 | $37.33 10-Q · filed 2017-11-02 | |
| 2016-06-30 | $37.55 10-Q · filed 2017-08-03 | |
| 2016-03-31 | $30.70 10-K · filed 2019-05-13 | |
| 2015-12-31 | $30.63 10-Q · filed 2017-02-02 | |
| 2015-09-30 | $30.42 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $29.95 10-Q · filed 2016-08-04 | |
| 2015-03-31 | $23.40 10-K · filed 2018-05-10 | |
| 2014-12-31 | $23.09 10-Q · filed 2016-02-04 | |
| 2014-09-30 | $22.19 10-Q · filed 2015-11-05 | |
| 2014-06-30 | $19.85 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $15.24 10-K · filed 2017-05-17 | |
| 2013-12-31 | $15.18 10-Q · filed 2015-02-05 | |
| 2013-09-30 | $15.02 10-Q · filed 2014-11-06 | |
| 2013-06-30 | $13.19 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $10.43 10-K · filed 2016-05-17 | |
| 2012-12-31 | $10.26 10-Q · filed 2014-02-07 | |
| 2012-09-30 | $9.43 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $9.37 10-Q · filed 2013-08-01 | |
| 2012-03-31 | $8.44 10-K · filed 2015-05-14 | |
| 2011-12-31 | $8.48 10-Q · filed 2013-02-07 | |
| 2011-09-30 | $8.58 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $8.62 10-Q · filed 2012-08-09 | |
| 2011-03-31 | $8.19 10-K · filed 2014-05-19 | |
| 2010-03-31 | $8.50 10-K · filed 2013-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |